Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-019216
Filing Date
2024-03-01
Accepted
2024-03-01 21:45:23
Documents
1
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4488
  Complete submission text file 0001213900-24-019216.txt   5838
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Issuer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 51 BARBAREE WAY TIBURON CA 94920
Business Address
Currie Graeme Martin (Reporting) CIK: 0001965006 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40804 | Film No.: 24712694